September 2, 2009; doi:10.1152/ajpregu.00343.2009.-Gastric bypass surgery efficiently and lastingly reduces excess body weight and reverses type 2 diabetes in obese patients. Although increased energy expenditure may also play a role, decreased energy intake is thought to be the main reason for weight loss, but the mechanisms involved are poorly understood. Therefore, the aim of this study was to characterize the changes in ingestive behavior in a rat model of Roux-en-Y gastric bypass surgery (RYGB). Obese (24% body fat compared with 18% in chow-fed controls), male Sprague-Dawley rats maintained for 15 wk before and 4 mo after RYGB or sham-surgery on a two-choice low-fat/high-fat diet, were subjected to a series of tests assessing energy intake, meal patterning, and food choice. Although sham-operated rats gained an additional 100 g body wt during the postoperative period, RYGB rats lost ϳ100 g. Intake of a nutritionally complete and palatable liquid diet (Ensure) was significantly reduced by ϳ50% during the first 2 wk after RYGB compared with sham surgery. Decreased intake was the result of greatly reduced meal size with only partial compensation by meal frequency, and a corresponding increase in the satiety ratio. Similar results were obtained with solid food (regular or high-fat chow) 6 wk after surgery. In 12-to 24-h two-choice liquid or solid diet paradigms with nutritionally complete low-and high-fat diets, RYGB rats preferred the low-fat choice (solid) or showed decreased acceptance for the high-fat choice (liquid), whereas sham-operated rats preferred the high-fat choices. A separate group of rats offered chow only before surgery completely avoided the solid high-fat diet in a choice paradigm. The results confirm anecdotal reports of "nibbling" behavior and fat avoidance in RYGB patients and provide a basis for more mechanistic studies in this rat model. obesity; diabetes; bariatric surgery; high-fat diet; food preference; meal patterns; satiety ratio THE DISAPPOINTING EFFECTIVENESS and serious side effects of drugs have made surgical approaches very attractive alternatives for treatment or even prevention of obesity, type 2 diabetes, and other sequelae of the metabolic syndrome. Major progress in surgical methodology and experience with an increasing number of operations each year has resulted in a much-improved rate of serious complications and mortality during the last decade. Large prospective studies with up to 15 years follow-up have shown that an obese patient with a body mass index (BMI) of Ն35 has a longer life expectancy with gastric bypass surgery than without, and a Ͼ80% chance of resolving preexisting diabetes, cardiovascular disease, and sleep apneas (1,5,25,33,42,43).Given these impressive effects and the expected continued rise in the number of bariatric surgeries, it is vexing not to understand the mechanisms involved. Identification of these mechanisms should eventually lead to the development of pharmacological or behavioral tools without the need for surgery, or less invasive surgery...